1. Do anticancer agents reach the tumor target in the human brain?

   • M. G. Donelli
   • M. Zucchetti
   • M. D'Incalci

   Review Pages: 251 - 260

2. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice

   • William R. Waud
   • Jacqueline Plowman
   • Daniel P. Griswold Jr.

   Original Articles Pages: 261 - 266

3. Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin

   • Roman Perez-Soler
   • Waldemar Priebe

   Original Articles Pages: 267 - 271

4. Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas

   • David C. Smith
   • Nicholas A. Vick
   • S. Clifford Schold Jr.

   Original Articles Pages: 272 - 276

5. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ

   • Cai Grau
   • Jens Overgaard

   Original Articles Pages: 277 - 280

6. Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma

   • Horng-Chyi Chang
   • Chyong-Huey Lai
   • Yung-Kuei Soong

   Original Articles Pages: 281 - 285

7. Vincristine potentiates cytochalasin B-induced DNA fragmentation in vitro

   • Michael A. Kolber
   • Patricia Hill

   Original Articles Pages: 286 - 290

8. Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a cancer and leukemia group B study

   • Jeffrey B. Hargis
   • James R. Anderson
   • David A. Van Echo

   Original Articles Pages: 291 - 296

9. A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions

   • Howard Bailey
   • George Wilding
   • David R. Spriggs

   Original Articles Pages: 297 - 302

10. High-performance liquid chromatographic analysis of idarubicin and fluorescent metabolites in biological fluids

    • Carlo M. Camaggi
    • Patrizia Carisi
    • Franco Pannuti

    Original Articles Pages: 303 - 306

11. Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study

    • Carlo M. Camaggi
    • Elena Strocchi
    • Franco Pannuti

    Original Articles Pages: 307 - 316

12. Renal handling of carboplatin

    • Bente T. Sørensen
    • Annette Strömgren
    • Anders Jakobsen

    Original Articles Pages: 317 - 320

13. Phase I trial of a 72-h continuous-infusion schedule of fazarabine

    • Robert Amato
    • Dah Ho
    • Martin Raber

    Original Articles Pages: 321 - 324

14. Benzamide potentiation of the cytotoxicity of bifunctional galacticol in resistant P388 leukemia correlates with inhibition of DNA ligase II

    • Etel Institoris
    • Brian W. Fox
    • István Pályi

    Original Articles Pages: 325 - 329

15. Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach

    • N. B. Tsavaris
    • P. Komitsopoulou
    • P. Kosmidis

    Short Communication Pages: 330 - 333